Skip to content

Clinical trials

Phase 2 Dry Eye Syndromes trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dry Eye Syndromes Phase: Phase 2 Clear all

173 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20042
20052
20061
20077
200810
20096
20107
20115
20125
20131
20147
20154
20165
20178
201812
20198
20205
202118
20229
202312
20249
202512
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed132
Unknown status10
Recruiting9
Terminated8
Not yet recruiting7
Withdrawn4
Active, not recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bausch & Lomb Incorporated8
Aldeyra Therapeutics, Inc.6
Dompé Farmaceutici S.p.A5
Kissei Pharmaceutical Co., Ltd.5
ORA, Inc.5
Oyster Point Pharma, Inc.5
Alcon Research4
Novartis Pharmaceuticals4
Allergan3
Ocular Therapeutix, Inc.3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dry Eye Syndromes173
Keratoconjunctivitis Sicca17
Sjogren's Syndrome10
Corneal Diseases7
Conjunctival Diseases5
Autoimmune Diseases4
Eye Diseases4
Xerostomia4
Graft vs Host Disease3
Xerophthalmia3

Trials

Showing 26 to 50 of 173. Each trial links to its page on Pharma Observatory.

73 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.